Min Hee Hong
0000-0003-3490-2195
Yonsei Cancer Center
2 papers found
Refreshing results…
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17–11)
Blocking TIM-3 in Treatment-Refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody
Missing publications? Search for publications with a matching author name.